Harbour Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.3K | Buy |
96
+5
| +5% | +$1.63K | ﹤0.01% | 2027 |
|
|
2025
Q1 | $24.6K | Sell |
91
-42
| -32% | -$11.3K | ﹤0.01% | 2096 |
|
|
2024
Q4 | $31.3K | Buy |
133
+2
| +2% | +$471 | ﹤0.01% | 1929 |
|
|
2024
Q3 | $36K | Buy |
131
+5
| +4% | +$1.38K | ﹤0.01% | 1820 |
|
|
2024
Q2 | $30.6K | Buy |
126
+24
| +24% | +$5.83K | ﹤0.01% | 1770 |
|
|
2024
Q1 | $15.2K | Sell |
102
-8
| -7% | -$1.2K | ﹤0.01% | 2068 |
|
|
2023
Q4 | $21.1K | Buy |
110
+57
| +108% | +$10.9K | ﹤0.01% | 1850 |
|
|
2023
Q3 | $9.39K | Buy |
53
+6
| +13% | +$1.06K | ﹤0.01% | 2049 |
|
|
2023
Q2 | $8.93K | Buy |
47
+2
| +4% | +$380 | ﹤0.01% | 2085 |
|
|
2023
Q1 | $9.01K | Buy |
45
+4
| +10% | +$801 | ﹤0.01% | 2052 |
|
|
2022
Q4 | $9.74K | Buy |
+41
| New | +$9.74K | ﹤0.01% | 1963 |
|